FibroTest-ActiTest as a non-invasive marker of liver fibrosis
about
Comparison of ELF, FibroTest and FibroScan for the non-invasive assessment of liver fibrosisRole of diet on non-alcoholic fatty liver disease: An updated narrative reviewPerformance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient dataEfficacy and safety of tenofovir disoproxil fumarate in Asian-Americans with chronic hepatitis B in community settingsDiscordance between liver biopsy and FibroTest in assessing liver fibrosis in chronic hepatitis B.A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers.Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of ageProspective validation of ELF test in comparison with Fibroscan and FibroTest to predict liver fibrosis in Asian subjects with chronic hepatitis B.Liver biopsy for histological assessment: The case against.Liver biopsy for histological assessment: The case in favorNoninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.Similar efficacy and safety of tenofovir in Asians and non-Asians with chronic hepatitis B.Prospective validation of FibroTest in comparison with liver stiffness for predicting liver fibrosis in Asian subjects with chronic hepatitis B.Multiplex Serum Protein Analysis Identifies Novel Biomarkers of Advanced Fibrosis in Patients with Chronic Liver Disease with the Potential to Improve Diagnostic Accuracy of Established BiomarkersNon-invasive prediction of hepatic fibrosis in patients with chronic HCV based on the routine pre-treatment workup.SASLT practice guidelines: management of hepatitis C virus infection.Association of different types of liver disease with demographic and clinical factors.Future directions in the treatment of HIV-HBV coinfection.Association of Toll-Like Receptor 3 Single-Nucleotide Polymorphisms and Hepatitis C Virus Infection.Many patients with interleukin 28B genotypes associated with response to therapy are ineligible for treatment because of comorbidities.Rapid emergence of multimarker strategies in laboratory medicine.Nonalcoholic fatty liver disease: a challenge for pediatricians.FibroTest/Fibrosure for significant liver fibrosis and cirrhosis in chronic hepatitis B: a meta-analysis.Diagnosis and Management of Hepatitis C Virus Infection.Genetic Variants in Interleukin-28B Are Associated with Diabetes and Diabetes-Related Complications in Patients with Chronic Hepatitis C Virus Infection.Noninvasive assessment of hepatic fibrosis in patients with chronic hepatitis C using serum Fourier transform infrared spectroscopy.How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?Non-invasive biomarkers for monitoring the fibrogenic process in liver: a short survey.The role of the non-invasive serum marker FibroTest-ActiTest in the prediction of histological stage of fibrosis and activity in children with naïve chronic hepatitis B infection.Steatosis severity affects the diagnostic performances of noninvasive fibrosis tests in nonalcoholic fatty liver disease.PNPLA3 polymorphism influences liver fibrosis in unselected patients with type 2 diabetes.Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.Performance of the FibroTest cannot be accurately estimated in nine paediatric patients with advanced fibrosisNoninvasive Biomarkers of Liver Fibrosis: An Overview
P2860
Q21261905-D58F6E13-F1B4-45D7-BDDC-3A59B0FECFD3Q27000333-DE45EE64-B22D-472B-A74C-0B432D7EE830Q28481485-FEE67751-3D99-4E8F-B657-8DFEE70DEACDQ28540372-9D028D84-A80F-41D7-9BB1-AF97D7E0249EQ30458298-F643975C-4585-47E9-BAFA-38C19B34FDCBQ30476922-8365BA81-1605-4ECF-9D48-E1609F6361C6Q33562288-FB4C5325-8A1E-42ED-BEC4-5047525C1A0CQ33671532-4F658B56-1D5E-4E19-9741-908F050FD044Q33872843-E0736311-768B-4B0D-99CB-9DF430FE2059Q34359330-49A624DB-9B25-4556-B167-CB93B935965BQ34469006-121F9B73-53E1-489E-80DE-191401D6F804Q34469014-0B50124C-C74C-43DD-89B2-2EBB913EE291Q34892910-CB22361F-9B11-4D54-9FEA-A043A184A784Q35594210-090847A7-71E6-49DF-9133-42D7C237C22BQ35908687-F09C8884-B2D6-4C2B-9911-CDE11E646623Q36197398-8AB89EEB-46E4-49DD-910D-C64768D8ABB6Q36546657-B0E8B4D9-F2F2-41FB-9C6D-38A9505D380CQ37019765-89C2D823-76F8-4D6E-8424-D45D06EB78FCQ37200697-45E4E741-8B19-4C24-96F2-CB3CBFF62902Q37439933-18A1F683-48FC-46F2-A54E-D1AD94C5ED26Q37588732-ED813978-59BD-45E4-9D5A-727C87316818Q37678082-B3BBBC55-53C5-458D-A6A7-34D9264C7126Q37680975-C32D2321-720D-4022-BF63-4D3F8A2C22AFQ37788538-0C02B767-6BDC-450D-A708-C78E6911498DQ38188809-53BBC6DC-D4CA-40AF-A43E-2B489AE42474Q38327430-D164B39E-219B-4713-9393-09D42CBBBA18Q41495145-9626F4DE-396D-43E0-AE26-262D740DB5A4Q43040660-10FFE1DD-AF64-4649-9893-0EF760B1147CQ43046834-BDA89FAB-5F72-4BBF-97B3-E654E55523C5Q43056949-3E2CBADA-3A02-4584-91E1-017AE3C40CF8Q43080292-4A0B4CC2-7E2D-4B39-8576-2E5C66C51171Q48056257-8B04057D-F232-4DE9-8C75-E7F658E82AF7Q51439742-F652EDE9-9492-4ECE-A5B6-96BD17AB2416Q51509141-ADA55B8D-D4B4-449B-8645-1D3B8F422140Q58622642-28836AFF-9045-4886-8E4D-B42D64697EECQ59050387-BEA3973C-FF02-402F-A8C7-6956CFAF2A32
P2860
FibroTest-ActiTest as a non-invasive marker of liver fibrosis
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
FibroTest-ActiTest as a non-invasive marker of liver fibrosis
@ast
FibroTest-ActiTest as a non-invasive marker of liver fibrosis
@en
FibroTest-ActiTest as a non-invasive marker of liver fibrosis
@nl
type
label
FibroTest-ActiTest as a non-invasive marker of liver fibrosis
@ast
FibroTest-ActiTest as a non-invasive marker of liver fibrosis
@en
FibroTest-ActiTest as a non-invasive marker of liver fibrosis
@nl
prefLabel
FibroTest-ActiTest as a non-invasive marker of liver fibrosis
@ast
FibroTest-ActiTest as a non-invasive marker of liver fibrosis
@en
FibroTest-ActiTest as a non-invasive marker of liver fibrosis
@nl
P3181
P1476
FibroTest-ActiTest as a non-invasive marker of liver fibrosis
@en
P2093
Mona Munteanu
Philippe Halfon
P3181
P356
10.1016/S0399-8320(08)73991-5
P407
P433
P577
2008-09-01T00:00:00Z